The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124192443 12419244 3 F 20160524 20160704 20160531 20160715 EXP PT-ROCHE-1766435 ROCHE 53.00 YR F Y 66.00000 KG 20160715 PH PT PT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124192443 12419244 1 PS PERJETA PERTUZUMAB 1 Intravenous (not otherwise specified) H0132B04 125409 840 MG SOLUTION FOR INFUSION
124192443 12419244 2 SS HERCEPTIN TRASTUZUMAB 1 Intravenous (not otherwise specified) H4619H05 103792 528 MG SOLUTION FOR INFUSION
124192443 12419244 3 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 5GJ5024 0 132 MG SOLUTION FOR INFUSION
124192443 12419244 4 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) DESCONHECIDO 0 1 DF BID
124192443 12419244 5 C SALBUTAMOL ALBUTEROL 1 Respiratory (inhalation) 1 DOSE IN SOS, VIA INHALATION 0
124192443 12419244 6 C AAS ASPIRIN 1 Unknown DESCONHECIDO 0 150 MG TABLET QD
124192443 12419244 7 C FORMOTEROL FORMOTEROL 1 Respiratory (inhalation) 4.5 G/DOSE, 2 DOSES/DAY 0
124192443 12419244 8 C BUDESONIDE. BUDESONIDE 1 Respiratory (inhalation) 160 G/DOSE 0
124192443 12419244 9 C ASPIRIN. ASPIRIN 1 Oral 0 150 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124192443 12419244 1 HER-2 positive breast cancer
124192443 12419244 2 HER-2 positive breast cancer
124192443 12419244 3 HER-2 positive breast cancer
124192443 12419244 4 Chronic obstructive pulmonary disease
124192443 12419244 5 Chronic obstructive pulmonary disease
124192443 12419244 6 Thrombocytosis
124192443 12419244 7 Chronic obstructive pulmonary disease
124192443 12419244 8 Chronic obstructive pulmonary disease
124192443 12419244 9 Thrombocytosis

Outcome of event

Event ID CASEID OUTC COD
124192443 12419244 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
124192443 12419244 Acute kidney injury
124192443 12419244 Anaemia
124192443 12419244 Blood creatinine increased
124192443 12419244 Blood urea increased
124192443 12419244 Blood uric acid increased
124192443 12419244 C-reactive protein increased
124192443 12419244 Hypochromic anaemia
124192443 12419244 Infection
124192443 12419244 Leukocytosis
124192443 12419244 Metabolic acidosis
124192443 12419244 Microcytic anaemia
124192443 12419244 Multiple organ dysfunction syndrome
124192443 12419244 Neutrophil count increased
124192443 12419244 Oliguria
124192443 12419244 Pneumocystis jirovecii pneumonia
124192443 12419244 Pyrexia
124192443 12419244 Renal function test abnormal
124192443 12419244 Respiratory failure
124192443 12419244 Sepsis
124192443 12419244 Tachycardia
124192443 12419244 Tachypnoea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124192443 12419244 1 20160505 20160505 0
124192443 12419244 2 20160506 20160506 0
124192443 12419244 3 20160506 20160506 0
124192443 12419244 6 201511 0